2023-24 financial results for cost recovery activities for listing medicines on the PBS and designated vaccines on the NIP

Page last updated: 4 December 2024

The PBS and NIP Cost Recovery Implementation Statement (CRIS) has been updated to include 2023-24 end-of-year financial results and is now available on the Cost Recovery Fees and Charges webpage.

In 2023-24 there was under-recovery of expenses for listing and management of products on the PBS and NIP. The under-recovery is due a combination of factors including: lower than expected volumes overall in 2023-24, fee waivers and exemptions, and post-listing services not charged.

The Australian Government Charging Framework requires the CRIS to be updated with end-of-year financial outcomes. This provides transparent information to industry on cost recovery for the demand-driven PBS program.

For any queries please contact: pbscostrecovery@health.gov.au.